Pharsight

Lucentis patents expiration

List of large molecules

Patent Number Company Patent Title Patent Expiry Activity Alert
US6407213 GENENTECH, INC. Method for making humanized antibodies
Jun, 2020

(3 years ago)

US6716602 GENENTECH, INC. Metabolic rate shifts in fermentations expressing recombinant proteins
Nov, 2021

(2 years ago)

US6828121 GENENTECH, INC. Bacterial host strains
Jul, 2022

(1 year, 9 months ago)

US9688775 GENENTECH, INC. System for antibody expression and assembly
Dec, 2022

(1 year, 3 months ago)

US6921659 GENENTECH, INC. Protease-deficient cells
Oct, 2023

(6 months ago)

US8383773 GENENTECH, INC. Protein product and method for reducing biomass-biomass interactions
Dec, 2023

(4 months ago)

US8574869 GENENTECH, INC. Prevention of disulfide bond reduction during recombinant production of polypeptides
Jul, 2028

(4 years from now)

US10421984 GENENTECH, INC. Methods for reducing norleucine misincorporation into proteins using a microorganism comprising a mutant metA allele
Sep, 2033

(9 years from now)

US9765379 GENENTECH, INC. Harvest operations for recombinant proteins
Mar, 2034

(9 years from now)

US10017732 GENENTECH, INC. Cell culture compositions with antioxidants and methods for polypeptide production
Mar, 2034

(9 years from now)

US10829732 GENENTECH, INC. Cell culture compositions with antioxidants and methods for polypeptide production
Mar, 2034

(9 years from now)

US10112994 GENENTECH, INC. Methods of producing two chain proteins in bacteria
Nov, 2035

(11 years from now)

Ingredients: RANIBIZUMAB